Shane Hegarty - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 

8/33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tian F, Cheng Y, Zhou S, Wang Q, Monavarfeshani A, Gao K, Jiang W, Kawaguchi R, Wang Q, Tang M, Donahue R, Meng H, Zhang Y, Jacobi A, Yan W, ... ... Hegarty S, et al. Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells. Neuron. 111: 444. PMID 36731430 DOI: 10.1016/j.neuron.2023.01.008  0.617
2022 Tian F, Cheng Y, Zhou S, Wang Q, Monavarfeshani A, Gao K, Jiang W, Kawaguchi R, Wang Q, Tang M, Donahue R, Meng H, Zhang Y, Jacobi A, Yan W, ... ... Hegarty S, et al. Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells. Neuron. PMID 35767995 DOI: 10.1016/j.neuron.2022.06.003  0.612
2022 Hegarty SV, Stanicka J. K/Cl co-transporter-2 upmodulation: a multi-modal therapy to treat spinal cord injury. Neural Regeneration Research. 17: 1984-1986. PMID 35142685 DOI: 10.4103/1673-5374.335155  0.739
2021 Arcuri J, Hegarty S, He Z, Bhattacharya SK. Lipidomics dataset of PTEN deletion-induced optic nerve regeneration mouse model. Data in Brief. 34: 106699. PMID 33457476 DOI: 10.1016/j.dib.2020.106699  0.46
2020 Liu Y, Hegarty S, Winter C, Wang F, He Z. Viral vectors for neuronal cell type-specific visualization and manipulations. Current Opinion in Neurobiology. 63: 67-76. PMID 32344323 DOI: 10.1016/J.Conb.2020.03.011  0.714
2018 Chen B, Li Y, Yu B, Zhang Z, Brommer B, Williams PR, Liu Y, Hegarty SV, Zhou S, Zhu J, Guo H, Lu Y, Zhang Y, Gu X, He Z. Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations. Cell. 174: 1599. PMID 30193115 DOI: 10.1016/J.Cell.2018.08.050  0.714
2018 Chen B, Li Y, Yu B, Zhang Z, Brommer B, Williams PR, Liu Y, Hegarty SV, Zhou S, Zhu J, Guo H, Lu Y, Zhang Y, Gu X, He Z. Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations. Cell. PMID 30033363 DOI: 10.1016/J.Cell.2018.06.005  0.733
2016 Hegarty SV, O'Leary E, Solger F, Stanicka J, Sullivan AM, O'Keeffe GW. A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease. Neurotoxicity Research. PMID 27256286 DOI: 10.1007/S12640-016-9636-2  0.719
Low-probability matches (unlikely to be authored by this person)
2017 Hegarty SV, Wyatt SL, Howard L, Stappers E, Huylebroeck D, Sullivan AM, O'Keeffe GW. Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation. Scientific Reports. 7: 8568. PMID 28819210 DOI: 10.1038/S41598-017-08900-3  0.268
2015 Hegarty SV, Sullivan AM, O'Keeffe GW. Zeb2: A multifunctional regulator of nervous system development. Progress in Neurobiology. 132: 81-95. PMID 26193487 DOI: 10.1016/J.Pneurobio.2015.07.001  0.247
2017 O'Keeffe GW, Hegarty SV, Sullivan AM. Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease. Neuronal Signaling. 1: NS20170027. PMID 32714578 DOI: 10.1042/NS20170027  0.245
2013 Hegarty SV, O'Keeffe GW, Sullivan AM. BMP-Smad 1/5/8 signalling in the development of the nervous system. Progress in Neurobiology. 109: 28-41. PMID 23891815 DOI: 10.1016/J.Pneurobio.2013.07.002  0.225
2015 Collins LM, Adriaanse LJ, Theratile SD, Hegarty SV, Sullivan AM, O'Keeffe GW. Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult. Molecular Neurobiology. 51: 1432-42. PMID 25065734 DOI: 10.1007/S12035-014-8820-8  0.222
2016 Hegarty SV, Sullivan AM, O'Keeffe GW. Protocol for evaluation of neurotrophic strategies in Parkinson's disease-related dopaminergic and sympathetic neurons . Journal of Biological Methods. 3: e50. PMID 31453215 DOI: 10.14440/jbm.2016.124  0.204
2018 Hegarty SV, Sullivan AM, O'Keeffe GW. Inhibition of promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson's disease. Neuronal Signaling. 2: NS20170181. PMID 32714583 DOI: 10.1042/NS20170181  0.201
2014 Hegarty SV, O'Keeffe GW, Sullivan AM. Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease. Neural Regeneration Research. 9: 1708-11. PMID 25422631 DOI: 10.4103/1673-5374.143410  0.201
2013 Hegarty SV, Sullivan AM, O'Keeffe GW. BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons. Molecular and Cellular Neurosciences. 56: 263-71. PMID 23831389 DOI: 10.1016/J.Mcn.2013.06.006  0.198
2014 Hegarty SV, Sullivan AM, O'Keeffe GW. Roles for the TGFβ superfamily in the development and survival of midbrain dopaminergic neurons. Molecular Neurobiology. 50: 559-73. PMID 24504901 DOI: 10.1007/S12035-014-8639-3  0.195
2014 Hegarty SV, Collins LM, Gavin AM, Roche SL, Wyatt SL, Sullivan AM, O'Keeffe GW. Canonical BMP-Smad signalling promotes neurite growth in rat midbrain dopaminergic neurons. Neuromolecular Medicine. 16: 473-89. PMID 24682653 DOI: 10.1007/S12017-014-8299-5  0.194
2017 Hegarty SV, Sullivan AM, O'Keeffe GW. Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease. Neural Regeneration Research. 12: 1814-1815. PMID 29239326 DOI: 10.4103/1673-5374.219039  0.193
2017 Hegarty SV, Togher KL, O'Leary E, Solger F, Sullivan AM, O'Keeffe GW. Romidepsin induces caspase-dependent cell death in human neuroblastoma cells. Neuroscience Letters. 653: 12-18. PMID 28506690 DOI: 10.1016/J.Neulet.2017.05.025  0.187
2016 Hegarty SV, Sullivan AM, O'Keeffe GW. The Epigenome as a therapeutic target for Parkinson's disease. Neural Regeneration Research. 11: 1735-1738. PMID 28123403 DOI: 10.4103/1673-5374.194803  0.183
2016 Hegarty S, O’Leary E, Solger F, Wyatt S, Sullivan A, O’Keeffe G. Novel neurotrophic strategy: interrogation of intracellular molecules regulating growth of midbrain dopaminergic neurons European Neuropsychopharmacology. 26: S127. DOI: 10.1016/S0924-977X(16)30905-1  0.182
2017 Hegarty SV, Sullivan AM, O'Keeffe GW. Endocytosis contributes to BMP2-induced Smad signalling and neuronal growth. Neuroscience Letters. PMID 28188849 DOI: 10.1016/J.Neulet.2017.02.013  0.182
2013 Hegarty SV, Sullivan AM, O'Keeffe GW. Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development. Developmental Biology. 379: 123-38. PMID 23603197 DOI: 10.1016/J.Ydbio.2013.04.014  0.176
2019 Alshangiti AM, Tuboly E, Hegarty SV, McCarthy CM, Sullivan AM, O'Keeffe GW. 4-Hydroxychalcone Induces Cell Death via Oxidative Stress in -Amplified Human Neuroblastoma Cells. Oxidative Medicine and Cellular Longevity. 2019: 1670759. PMID 31885773 DOI: 10.1155/2019/1670759  0.163
2014 Hegarty SV, Spitere K, Sullivan AM, O'Keeffe GW. Ventral midbrain neural stem cells have delayed neurogenic potential in vitro. Neuroscience Letters. 559: 193-8. PMID 24342440 DOI: 10.1016/J.Neulet.2013.12.009  0.147
2015 Hegarty SV, Sullivan AM, O'Keeffe GW. Zeb2: A multifunctional regulator of nervous system development Progress in Neurobiology. DOI: 10.1016/j.pneurobio.2015.07.001  0.146
2019 Alshangiti AM, Togher KL, Hegarty SV, Sullivan AM, O'Keeffe GW. The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells. Health Psychology and Behavioral Medicine. 3: NS20180201. PMID 32269833 DOI: 10.1042/Ns20180201  0.135
2020 Hegarty SV, Green HF, Niclis J, O'Keeffe GW, Sullivan AM. Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease. Frontiers in Neuroscience. 14: 515. PMID 32655345 DOI: 10.3389/Fnins.2020.00515  0.128
2020 Alshangiti AM, Wyatt SL, McCarthy E, Collins LM, Hegarty SV, Sullivan AM, O'Keeffe GW. Association of distinct type 1 bone morphogenetic protein receptors with different molecular pathways and survival outcomes in neuroblastoma. Neuronal Signaling. 4: NS20200006. PMID 32714600 DOI: 10.1042/NS20200006  0.113
2017 Hegarty SV, Lee DJ, O'Keeffe GW, Sullivan AM. Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysis. Parkinsonism & Related Disorders. PMID 28215730 DOI: 10.1016/J.Parkreldis.2017.02.011  0.087
2017 Curran EA, O'Keeffe GW, Looney AM, Moloney G, Hegarty SV, Murray DM, Khashan AS, Kenny LC. Exposure to Hypertensive Disorders of Pregnancy Increases the Risk of Autism Spectrum Disorder in Affected Offspring. Molecular Neurobiology. PMID 28975539 DOI: 10.1007/s12035-017-0794-x  0.041
Hide low-probability matches.